Application

18124943 · USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

Filed 2023-03-22 · Abandoned The official file ↗ · Art unit 1612 · Examiner Frederick F Krass Hard · CPC A61K 31/4174 · BioXcel Therapeutics, Inc. · COOLEY LLP / BioXcel Therapeutics

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

3.3 mo

to disposition 20.5 mo

Statutes raised

103 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.